Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
Although the combination of statin and fenofibrate is one of the options for patients with
combined hyperlipidemia, non-lipid effects of it has not been completely understood yet. In
this study we compared the effects of rosuvastatin 10 mg/fenofibrate 160 mg combination and
rosuvastatin 10 mg monotherapy on muscle and liver enzyme, homocysteine levels, kidney, blood
glucose control, and blood cell counts.